Nevada Center For Dermatology

CLIA Laboratory Citation Details

3
Total Citations
19
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 29D0965583
Address 650 Sierra Rose Dr Ste A, Reno, NV, 89511
City Reno
State NV
Zip Code89511
Phone(775) 827-8100

Citation History (3 surveys)

Survey - June 11, 2025

Survey Type: Standard

Survey Event ID: BXZ311

Deficiency Tags: D0000 D5217 D6120 D0000 D5217 D6120

Summary:

Summary Statement of Deficiencies D0000 This Statement of Deficiencies was created as a result of an on-site CLIA recertification survey conducted at your facility on June 11, 2025. The findings and conclusions of any investigation by the Division of Public and Behavioral Health shall not be construed as prohibiting any criminal or civil investigations, actions or other claims for relief that may be available to any party under applicable federal, state, or local laws. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on a review of the roster provided on the CMS-209 form, a review of the 2023 and 2024 laboratory records for the twice per year verification of accuracy for Mohs testing, and an interview with the Office Manager, the laboratory failed to ensure that twice per year verification of accuracy was performed for each provider performing Mohs testing in the laboratory. Findings include: 1. Testing personnel number two on the CMS-209 form did not have documentation of any accuracy checks in 2024. 2. An interview with the Office Manager on June 11, 2025 at approximately 10:30 AM confirmed these findings. The laboratory performs approximately 424 Histopathology tests annually. D6120 TECHNICAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1451(b)(7)(8) (b)(7) Identifying training needs and assuring that each individual performing tests receives regular in-service training and education appropriate for the type and complexity of the laboratory services performed; (b)(8) Evaluating the competency of Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- all testing personnel and assuring that the staff maintain their competency to perform test procedures and report test results promptly, accurately and proficiently. This STANDARD is not met as evidenced by: Based on a review of the roster provided on the CMS-209 form, a lack of annual competency assessments, an interview with the Office Manager, the technical supervisor failed to ensure that all testing personnel had documented annual competency assessments. Findings include: 1. Testing personnel two on the CMS-209 had no annual competency assessments for wet mount and KOH testing in 2023 and 2024. 2. Testing personnel three on the CMS-209 had no annual competency assessments for wet mount and KOH testing in 2023 and 2024. 3. An interview with the Office Manager on June 11, 2025 at approximately 10:30 AM confirmed these findings. The laboratory performs approximately 80 Mycology and Parasitology tests annually. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 25, 2023

Survey Type: Standard

Survey Event ID: H4M411

Deficiency Tags: D0000 D5217 D5413 D5217 D5413 D5891 D5891

Summary:

Summary Statement of Deficiencies D0000 This Statement of Deficiencies was created as a result of an on-site CLIA recertification survey conducted at your facility on July 25, 2023. The findings and conclusions of any investigation by the Division of Public and Behavioral Health shall not be construed as prohibiting any criminal or civil investigations, actions or other claims for relief that may be available to any party under applicable federal, state, or local laws. D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of the internal and external slide reviews performed as accuracy checks, the laboratory policies and procedures, and an interview with the office manager and laboratory director, the laboratory failed to ensure that twice a year accuracy checks were performed. Findings include: 1. A review of the internal and external slide reviews performed during 2022 and 2023 revealed that slides for one case of Mohs surgery had been sent to the American Society for Mohs Surgery for evaluation during 2022. There were no additional Mohs cases that were reviewed in order to complete the required twice per year accuracy check during 2022. 2. The laboratory procedure, "Quality Control," indicates that the laboratory is to participate in the American Society of Moh's Surgery Peer Review at least once a year. Additionally, one Moh's case is to be reviewed internally by a second provider to ensure accuracy. 3. An interview with the office manager and the laboratory director on July 25, 2023 at approximately 11:00 AM confirmed these findings. The laboratory performs approximately 350 histopathology tests annually. D5413 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- CFR(s): 493.1252(b) The laboratory must define criteria for those conditions that are essential for proper storage of reagents and specimens, accurate and reliable test system operation, and test result reporting. The criteria must be consistent with the manufacturer's instructions, if provided. These conditions must be monitored and documented and, if applicable, include the following: (1) Water quality. (2) Temperature. (3) Humidity. (4) Protection of equipment and instruments from fluctuations and interruptions in electrical current that adversely affect patient test results and test reports. This STANDARD is not met as evidenced by: Based on review of room, refrigerator, and cryostat temperature logs, and an interview with the office manager, the laboratory failed to ensure that the acceptable ranges for room, refrigerator, and cryostat temperatures were documented on the log sheets for each month. Findings include: 1. A review of room, refrigerator, and cryostat temperature logs from January 2022 through July 2023 revealed that the acceptable temperature ranges were not included on the log sheets from March 2023 through July 2023, therefore recorded temperatures could not be compared to the acceptable ranges. 2. An interview with the office manager on July 25, 2023, at approximately 10: 30 AM confirmed these findings. The laboratory performs approximately 70 microbiology and 350 histopathology tests annually. D5891 POSTANALYTIC SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1299(a) The laboratory must establish and follow written policies and procedures for an ongoing mechanism to monitor, assess and, when indicated, correct problems identified in the postanalytic systems specified in 493.1291. This STANDARD is not met as evidenced by: Based on a review of the laboratory policies and procedures and an interview with the office manager and the laboratory director, the laboratory failed to ensure that a written Quality Assurance (QA) procedure was established to identify and correct deficiencies in quality. Findings include: 1. A review of the laboratory's policies and procedures revealed that there was no documented QA policy and procedure for the laboratory staff to follow in order to identify and correct deficiencies in quality. 2. These findings were confirmed in an interview with the office manger and the laboratory director on July 25, 2023, at approximately 11:00 AM. The laboratory performs approximately 70 microbiology and 350 histopathology tests annually. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - February 25, 2019

Survey Type: Standard

Survey Event ID: 73ZB11

Deficiency Tags: D0000 D5203 D5293 D0000 D5203 D5293

Summary:

Summary Statement of Deficiencies D0000 This Statement of Deficiencies was created as a result of an on-site CLIA recertification survey conducted at your facility on February 25, 2019. The findings and conclusions of any investigation by the Division of Public and Behavioral Health shall not be construed as prohibiting any criminal or civil investigations, actions or other claims for relief that may be available to any party under applicable federal, state, or local laws. D5203 SPECIMEN IDENTIFICATION AND INTEGRITY CFR(s): 493.1232 The laboratory must establish and follow written policies and procedures that ensure positive identification and optimum integrity of a patient's specimen from the time of collection or receipt of the specimen through completion of testing and reporting of results. This STANDARD is not met as evidenced by: Based on review of the Mohs accession log, Mohs maps, Mohs slides, and patients' electronic medical records, and interview with the laboratory personnel, the laboratory failed to follow established policies and procedures to ensure positive identification of patient specimens from collection to final report. Findings include: 1. A sample survey of seven random Mohs cases from 4/2017 to 2/2019 revealed that in one of seven cases, the name was misspelled on the Mohs slides (Case #4411 from 1/29/18). The name on the Mohs map and Mohs accession log matched the name in the electronic medical record. 2. The sample survey revealed that in one of seven cases, the name was misspelled in the Mohs accession log (Case #4802 from 2/12/19). The name on the Mohs map and Mohs slides matched the name in the electronic medical record. 2. The laboratory personnel interviewed on 2/25/19 at approximately 11:00 AM confirmed the findings. The laboratory performs approximately 425 histopathology tests annually. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- D5293 GENERAL LABORATORY SYSTEMS QUALITY ASSESSMENT CFR(s): 493.1239(b)(c) (b) The general laboratory systems quality assessment must include a review of the effectiveness of

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access